HU9903560A3 - Quinoline and quinazoline derivatives - Google Patents

Quinoline and quinazoline derivatives

Info

Publication number
HU9903560A3
HU9903560A3 HU9903560A HU9903560A HU9903560A3 HU 9903560 A3 HU9903560 A3 HU 9903560A3 HU 9903560 A HU9903560 A HU 9903560A HU 9903560 A HU9903560 A HU 9903560A HU 9903560 A3 HU9903560 A3 HU 9903560A3
Authority
HU
Hungary
Prior art keywords
quinoline
quinazoline derivatives
quinazoline
derivatives
Prior art date
Application number
HU9903560A
Other versions
HU9903560A2 (en
Original Assignee
Pfizer Res And Dev Company Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GBGB9526546.8A priority Critical patent/GB9526546D0/en
Application filed by Pfizer Res And Dev Company Nv filed Critical Pfizer Res And Dev Company Nv
Publication of HU9903560A2 publication Critical patent/HU9903560A2/en
Publication of HU9903560A3 publication Critical patent/HU9903560A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/42Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/94Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/95Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D497/00Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D497/02Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D497/04Ortho-condensed systems
HU9903560A 1995-12-23 1996-12-05 Quinoline and quinazoline derivatives HU9903560A3 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB9526546.8A GB9526546D0 (en) 1995-12-23 1995-12-23 Compounds useful in therapy

Publications (2)

Publication Number Publication Date
HU9903560A2 HU9903560A2 (en) 2000-05-28
HU9903560A3 true HU9903560A3 (en) 2000-07-28

Family

ID=10786091

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9903560A HU9903560A3 (en) 1995-12-23 1996-12-05 Quinoline and quinazoline derivatives

Country Status (34)

Country Link
US (3) US6103738A (en)
EP (1) EP0877734B1 (en)
JP (1) JP3070958B2 (en)
KR (1) KR19990076693A (en)
AP (1) AP715A (en)
AR (1) AR005166A1 (en)
AT (1) AT194598T (en)
AU (1) AU708979B2 (en)
BG (1) BG102559A (en)
BR (1) BR9612263A (en)
CA (1) CA2236814C (en)
CO (1) CO4480106A1 (en)
CZ (1) CZ197698A3 (en)
DE (2) DE69609353T2 (en)
DK (1) DK0877734T3 (en)
ES (1) ES2151192T3 (en)
GB (1) GB9526546D0 (en)
GR (1) GR3034225T3 (en)
HN (1) HN1996000082A (en)
HR (1) HRP960616A2 (en)
HU (1) HU9903560A3 (en)
IS (1) IS4731A (en)
MA (1) MA26414A1 (en)
NO (1) NO982913L (en)
NZ (1) NZ325248A (en)
OA (1) OA10703A (en)
PL (1) PL327610A1 (en)
PT (1) PT877734E (en)
SK (1) SK81698A3 (en)
TN (1) TNSN96161A1 (en)
TR (1) TR199801195T2 (en)
WO (1) WO1997023462A1 (en)
YU (1) YU68896A (en)
ZA (1) ZA9610784B (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9526546D0 (en) * 1995-12-23 1996-02-28 Pfizer Ltd Compounds useful in therapy
GB9700504D0 (en) 1997-01-11 1997-02-26 Pfizer Ltd Pharmaceutical compounds
GB9708917D0 (en) * 1997-05-01 1997-06-25 Pfizer Ltd Compounds useful in therapy
GB9711220D0 (en) * 1997-05-30 1997-07-23 Isis Innovation Antiarrhythmic agents
GB9711650D0 (en) * 1997-06-05 1997-07-30 Pfizer Ltd Compounds useful in therapy
AT309240T (en) 2000-08-31 2005-11-15 Hoffmann La Roche Chinazolin derivatives as alpha-1 adrenerge antagonists
US6900220B2 (en) 2001-01-02 2005-05-31 Syntex (U.S.A.) Llc Quinazolone derivatives as alpha 1A/B adrenergic receptor antagonists
MXPA03005854A (en) * 2001-01-02 2003-09-10 Hoffmann La Roche Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists.
US6734303B2 (en) 2001-05-18 2004-05-11 Pfizer Inc. Process for the production of quinazolines
GB0206033D0 (en) 2002-03-14 2002-04-24 Pfizer Ltd Compounds useful in therapy
ES2400339T3 (en) * 2002-07-15 2013-04-09 Symphony Evolution, Inc. Compounds, pharmaceutical compositions thereof and their use in the treatment of cancer
WO2004029051A1 (en) 2002-09-26 2004-04-08 Pfizer Limited Pyrazole amides for treating hiv infections
AT402165T (en) 2003-04-23 2008-08-15 Glaxo Group Ltd Piperazine derivatives and its use in the treatment of neurological and psychiatric diseases.
US20050124562A1 (en) * 2003-09-23 2005-06-09 Joseph Guiles Bis-quinazoline compounds for the treatment of bacterial infections
CA2537812C (en) * 2003-09-26 2013-01-22 Exelixis, Inc. C-met modulators and method of use
ME02799B (en) * 2004-06-24 2018-01-20 Vertex Pharma Modulators of ATP-binding cassette transporters
DK1993360T3 (en) 2005-12-28 2017-05-22 Vertex Pharma Solid forms of n- [2,4-bis (1,1-dimethylethyl) -5-hydroxyphenyl] -1,4-dihydro-4-oxoquinolin-3-carboxamide
US8021677B2 (en) 2006-05-12 2011-09-20 Gore Enterprise Holdings, Inc. Immobilized biologically active entities having a high degree of biological activity
US8986713B2 (en) * 2006-05-12 2015-03-24 W. L. Gore & Associates, Inc. Medical device capable of being compacted and expanded having anti-thrombin III binding activity
US20080279909A1 (en) * 2006-05-12 2008-11-13 Cleek Robert L Immobilized Biologically Active Entities Having A High Degree of Biological Activity Following Sterilization
US8496953B2 (en) * 2006-05-12 2013-07-30 W. L. Gore & Associates, Inc. Immobilized biologically active entities having a high degree of biological activity following sterilization
US9114194B2 (en) * 2006-05-12 2015-08-25 W. L. Gore & Associates, Inc. Immobilized biologically active entities having high biological activity following mechanical manipulation
SG179418A1 (en) * 2007-03-14 2012-04-27 Exelixis Patent Co Llc Inhibitors of the hedgehog pathway
EP2346848B1 (en) 2008-11-14 2013-02-27 F.Hoffmann-La Roche Ag Quinazoline derivatives as nk3 receptor antagonists
EA201692224A1 (en) 2009-01-16 2017-12-29 Экселиксис, Инк. Malate salt n- (4 - {[6,7-bis (methyloxy) quinolin-4-il] oxy} phenyl) -n '- (4-fluorphenyl) cyclopropan-1,1-dicarboxamide and its crystallic forms for bulbs
SG193156A1 (en) 2009-03-20 2013-09-30 Vertex Pharma Process for making modulators of cystic fibrosis transmembrane conductance regulator
WO2010109185A2 (en) * 2009-03-23 2010-09-30 Cipla Limited Process for the preparation of doxazosin and salts thereof
CA2772642C (en) * 2009-09-03 2017-08-29 Bristol-Myers Squibb Company Quinazolines as potassium ion channel inhibitors
US8591932B2 (en) 2009-09-17 2013-11-26 W. L. Gore & Associates, Inc. Heparin entities and methods of use
CA2828797A1 (en) 2011-03-11 2012-09-20 Gore Enterprise Holdings, Inc. Single point attachment of heparin to hyperbranched polymers and coatings thereof
WO2013043255A1 (en) * 2011-09-21 2013-03-28 University Of South Alabama Methods and compositions for the treatment of ovarian cancer
RU2692779C2 (en) 2012-02-27 2019-06-27 Вертекс Фармасьютикалз Инкорпорейтед Pharmaceutical composition and introduction thereof
CA2943100C (en) * 2014-03-24 2017-04-04 Hao Wu Quinoline derivatives as smo inhibitors
MX2017004631A (en) 2014-10-07 2017-06-19 Vertex Pharma Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4656174A (en) * 1982-07-24 1987-04-07 Pfizer Inc. Quinoline therapeutic agents
GB8506174D0 (en) * 1985-03-09 1985-04-11 Pfizer Ltd 4-amino-6 7-dimethoxy-2-piperazin-1-ylquinazoline derivatives
GB8814458D0 (en) * 1988-06-17 1988-07-20 Wyeth John & Brother Ltd Heterocyclic compounds
GB9526546D0 (en) * 1995-12-23 1996-02-28 Pfizer Ltd Compounds useful in therapy

Also Published As

Publication number Publication date
US20020049322A1 (en) 2002-04-25
HU9903560A2 (en) 2000-05-28
US6642242B2 (en) 2003-11-04
JP3070958B2 (en) 2000-07-31
KR19990076693A (en) 1999-10-15
GR3034225T3 (en) 2000-12-29
CO4480106A1 (en) 1997-07-09
BG102559A (en) 1999-03-31
AU1371997A (en) 1997-07-17
SK81698A3 (en) 2000-04-10
DE69609353D1 (en) 2000-08-17
OA10703A (en) 2002-11-28
PL327610A1 (en) 1998-12-21
US6750214B2 (en) 2004-06-15
MA26414A1 (en) 2004-12-20
IS4731A (en) 1998-04-29
HRP960616A2 (en) 1998-06-30
BR9612263A (en) 1999-07-13
NO982913L (en) 1998-07-30
AT194598T (en) 2000-07-15
GB9526546D0 (en) 1996-02-28
JPH11501668A (en) 1999-02-09
DK0877734T3 (en) 2000-11-20
TNSN96161A1 (en) 2005-03-15
US20030220332A1 (en) 2003-11-27
TR199801195T2 (en) 1998-10-21
ZA9610784B (en) 1998-06-22
CZ197698A3 (en) 1999-03-17
CA2236814C (en) 2001-09-18
NO982913D0 (en) 1998-06-22
NZ325248A (en) 1999-09-29
AP9600900A0 (en) 1997-01-31
DE69609353T2 (en) 2000-12-07
AP715A (en) 1998-12-30
CA2236814A1 (en) 1997-07-03
PT877734E (en) 2000-12-29
DK877734T3 (en)
YU68896A (en) 1999-07-28
EP0877734A1 (en) 1998-11-18
WO1997023462A1 (en) 1997-07-03
EP0877734B1 (en) 2000-07-12
HN1996000082A (en) 1997-06-30
US6103738A (en) 2000-08-15
AR005166A1 (en) 1999-04-14
AU708979B2 (en) 1999-08-19
ES2151192T3 (en) 2000-12-16

Similar Documents

Publication Publication Date Title
DE69940128D1 (en) Quinazoline and pyridopyrimidine derivatives
AU732194C (en) Heterocyclic esters and amides
DK0915880T3 (en) Azolotriazines and pyrimidines
GB2297336B (en) Junction members and their uses
DE69634416D1 (en) Quinoline derivatives
GB2298422B (en) Compounds and their use
AU648110B2 (en) Quinazoline derivatives and their preparation
GB2324672B (en) Vision system and proximity detector
ZA9708452B (en) Hetaroyl derivatives
HU9802678A3 (en) Bicyclic amino derivatives and pgd2 antagonist containing the same
IL115341D0 (en) Quinoline and quinazoline derivatives their preparation and pharmaceutical compositions containing them
GR3018143T3 (en) Quinazoline derivatives.
GR3021326T3 (en) Quinazoline derivatives.
AU9790198A (en) Compounds and methods
HU9900666A3 (en) Phosphodiesterase inhibitor phenanthridines derivatives and use thereof
IL125685D0 (en) Quinazoline derivatives as antitumor agents
AU3701797A (en) Substituted pyrimidine derivatives and their pharmaceutical use
AU4997397A (en) Card-recognition and gaming-control device
AU4954097A (en) 2-pyrimidineamine derivatives and processes for their preparation
HK1001618A1 (en) Novel pyrimidine derivatives and processes for the preparation thereof
HRP970680A2 (en) New ketobenzamides and their use
AU8012294A (en) 1n-alkyl-n-arylpyrimidinamines and derivatives thereof
ZA9708451B (en) Hetaroyl derivatives
PL329195A1 (en) Derivatives of 6-phenylpyridol-2-amine
AU1866497A (en) 4-anilinoquinazoline derivatives